Illumina, Inc.

Tweet this page
<
2016
2017
2018
2019
2020
2021
2022
2023
>
Registration as it was on 05 Mar 2018
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

150,000€

Financial year: Jan 2017 - Dec 2017

Lobbyists (Full time equivalent)

0.25 Fte (1)

Lobbyists with EP accreditation

0

High-level Commission meetings

7

Lobbying Costs over the years

  • Info

    Illumina, Inc.

    EU Transparency Register

    547949121038-83 First registered on 11 Mar 2016

    Goals / Remit

    Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and follow @illumina.

    Main EU files targeted

    Illumina, Inc. follows policy and legislative developments related to genomics, agri-genomics, public health, animal health, agriculture, forensics, biotechnology, data protection, science, and research policies.

    Address

    Head Office
    5200 Illumina Way
    San Diego
    UNITED STATES
  • People

    Total lobbyists declared

    1

    Employment timeLobbyists
    25%1

    Lobbyists (Full time equivalent)

    0.25

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    0 accreditations were / are live (in bold) for the selected state of 05 Mar 2018

    Name Start date End Date
    Ms Marie Helene FANDEL 18 Oct 2023 17 Oct 2024
    Mr Federico PISANI 17 Aug 2023 16 Aug 2024
    Mr Jan NEUTZE 17 Dec 2022 16 Dec 2023
    Mr Federico PISANI 31 Aug 2022 17 Aug 2023
    Ms Miriam Gargesi 09 Aug 2022 05 Aug 2023
    Ms Miriam Gargesi 10 Oct 2018 10 Oct 2019

    Complementary Information

    Illumina is increasing its engagement with the European institutions and in the future, we expect that employees will devote more time to activities covered by the Register. We will update this section if the number of employees increases significantly.

    Person in charge of EU relations

    Ms Kathy Lynch (Senior Director, Global Government Affairs & Public Policy)

    Person with legal responsibility

    Mr Marc Stapley (Executive Vice President)

  • Categories

    Category

    II - In-house lobbyists and trade/business/professional associations

    Subcategory

    Companies & groups

  • Networking

    Affiliation

    None declared

    Member organisations

    None declared

  • Financial Data

    Closed financial year

    Jan 2017 - Dec 2017

    Lobbying costs for closed financial year

    150,000€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    None

    Communication activities

    None

    Other activities

    None declared

  • Meetings

    Meetings

    7 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

    • Date 03 Dec 2021 Location Brussels
      Subject Presentation of the merger case Illumina and Grail
      Cabinet Cabinet of Commissioner Elisa Ferreira
      Portfolio Cohesion and Reforms
      Attending
      • Carole Mancel-Blanchard (Cabinet member)
    • Date 03 Dec 2021 Location Brussels, Belgium
      Subject The public health benefits and competition issues arising out of the merger between Illumina and GRAIL
      Cabinet Cabinet of Commissioner Janusz Wojciechowski
      Portfolio Agriculture
      Attending
      • Joanna Stawowy (Cabinet member)
    • Date 03 Dec 2021 Location Video-conference
      Subject Presentation of an early screening test by a cancer screening start-up. Its impact on health, early detection of cancer and especially on most vulnerable groups was discussed in the context of equality policy and the EU Beating Cancer strategy
      Cabinet Cabinet of Commissioner Helena Dalli
      Portfolio Equality
      Attending
      • Eva Gerhards (Cabinet member)
    • Date 03 Dec 2021 Location Brussels
      Subject Healthcare benefits of Cancer test
      Cabinet Cabinet of Vice-President Margaritis Schinas
      Portfolio Promoting the European Way of Life
      Attending
      • Chris Uregian (Cabinet member)
    • Date 03 Dec 2021 Location Virtual
      Subject Cancer Screening tests, Illumina-GRAIL Merger
      Cabinet Cabinet of Commissioner Mairead Mcguinness
      Portfolio Financial services, financial stability and Capital Markets Union
      Attending
      • Katherine Power (Cabinet member)
    • Date 12 Nov 2021 Location Videconference
      Subject Challenges of the health industrial ecosystem
      Cabinet Cabinet of Commissioner Thierry Breton
      Portfolio Internal Market
      Attending
      • Maurits-Jan Prinz (Cabinet member)
    • Date 29 Sep 2021 Location Brussels (virtual)
      Subject Illumina/GRAIL transaction, which in addition to important competition policy questions
      Cabinet Cabinet of President Ursula von der Leyen
      Portfolio President
      Attending
      • Anthony Whelan (Cabinet member)
      Other Lobbyists
Download this datacard